Stock Events

Acadia Pharmaceuticals (ACAD) Q3 2016 Earnings

4AugConfirmed
Q4 2015
Q1 2016
Q2 2016
Q3 2016
-0.63
-0.55
-0.46
-0.38

Details

Expected EPS
-0.51
Actual EPS
-0.63
Surprise EPS
-0.12
Surprise Percent
+23.53%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.63 per share for Q3 2016.

0 Comments

Share your thoughts